Orphan nuclear receptor TR3/Nur77 biologics inhibit tumor growth by targeting angiogenesis and tumor cells
Authors:
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Microvascular Research
- Vol. 128, 103934
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01CA133235, R03CA191463, R01DK095873, R21DK080970)
- American Cancer Society (113297)
- China Scholarship Council
This publication has 24 references indexed in Scilit:
- Requirement of novel amino acid fragments of orphan nuclear receptor TR3/Nur77 for its functions in angiogenesisOncotarget, 2015
- Nur transcription factors in stress and addictionFrontiers in Molecular Neuroscience, 2013
- Molecular Pathways: The Role of NR4A Orphan Nuclear Receptors in CancerClinical Cancer Research, 2012
- Inflammation: a role for NR4A orphan nuclear receptors?Biochemical Society Transactions, 2011
- Activation of Nerve Growth Factor-Induced Bα by Methylene-Substituted Diindolylmethanes in Bladder Cancer Cells Induces Apoptosis and Inhibits Tumor GrowthMolecular Pharmacology, 2010
- Structural Basis for the Cell-specific Activities of the NGFI-B and the Nurr1 Ligand-binding DomainJournal of Biological Chemistry, 2005
- The Orphan Steroid Receptor Nur77 Family Member Nor-1 Is Essential for Early Mouse EmbryogenesisJournal of Biological Chemistry, 2003
- Nuclear Hormone Receptors and Gene ExpressionPhysiological Reviews, 2001
- Functional redundancy of the Nur77 and Nor‐1 orphan steroid receptors in T‐cell apoptosisThe EMBO Journal, 1997
- Unimpaired Thymic and Peripheral T Cell Death in Mice Lacking the Nuclear Receptor NGFI-B (Nur77)Science, 1995